5-fluoro-2,2'-cyclocytidine has been researched along with ancitabine in 5 studies
Studies (5-fluoro-2,2'-cyclocytidine) | Trials (5-fluoro-2,2'-cyclocytidine) | Recent Studies (post-2010) (5-fluoro-2,2'-cyclocytidine) | Studies (ancitabine) | Trials (ancitabine) | Recent Studies (post-2010) (ancitabine) |
---|---|---|---|---|---|
5 | 1 | 0 | 118 | 10 | 13 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M | 1 |
Meyers, PA; Redner, A; Steinherz, PG; Tan, CT | 1 |
du Plessis, HE; Falkson, G; Falkson, HC; Meyer, TE | 1 |
Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L | 1 |
Floersheim, GL; Torhorst, J | 1 |
1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and ancitabine
Article | Year |
---|---|
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine | 1981 |
4 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and ancitabine
Article | Year |
---|---|
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous | 1978 |
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male | 1989 |
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
Topics: Ancitabine; Antineoplastic Agents; Cytarabine; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Leukopenia; Male; Nausea; Vomiting | 1980 |
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer Cells, Natural; Leukemia, Experimental; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Moloney murine leukemia virus; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |